<DOC>
	<DOCNO>NCT02149641</DOCNO>
	<brief_summary>In treatment nasopharyngeal cancer , determine incidence high grade ( ≥G2 ) subjective xerostomia 1 year .</brief_summary>
	<brief_title>Parotid-sparing IMRT Nasopharyngeal Cancer</brief_title>
	<detailed_description>The purpose study determine feasibility deliver induction chemotherapy concomitant chemotherapy IMRT treatment locally advanced nasopharyngeal cancer determine incidence high grade ( ≥G2 ) subjective xerostomia 1 year .</detailed_description>
	<mesh_term>Nasopharyngeal Neoplasms</mesh_term>
	<criteria>nasopharyngeal cancer Patients &lt; 16 year old previous malignancy nonmelanomatous skin cancer exclude</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2014</verification_date>
</DOC>